study question: Are there improvements in the accuracy of prediction of ectopic pregnancy (EP) in women with early symptomatic pregnancy using human chorionic gonadotrophin (hCG) curves when clinicians consider visits beyond the first 48 h after initial presentation? main results and the role of chance: Using currently recommended prediction rules, adding a third hCG evaluation on Day 4 after initial presentation significantly improved the accuracy of initial prediction from the first two values (48 h apart, or Day 2) by 9.3% (P ¼ 0.015). Adding a third value on Day 7 improved prediction significantly by 6.7% (P ¼ 0.031), compared with prediction based on first two values. The improvement in prediction by assessing four hCG values (Days 0, 2, 4 and 7) compared with three values (Days 0, 2 and 4) was 1.3% and not statistically significant.
Introduction
Women who present with pain or bleeding during the first trimester of pregnancy are at risk of ectopic pregnancy (EP), a pregnancy implanted outside the endometrial cavity. EPs occur in 0.65 -2% of all pregnancies and may compromise a woman's health and future fertility, particularly if it causes rupture of a fallopian tube (Hoover et al., 2010) . EPs can be diagnosed using a combination of transvaginal sonography (TVS), clinical history and serial human chorionic gonadotrophin (hCG) levels (Seeber et al., 2006) . Early diagnosis can substantially decrease the risk of mortality (Barnhart, 2009) . A diagnosed EP can be treated surgically by dissecting the EP or removal of the fallopian tube, medically, typically with methotrexate, or with expectant management (Barnhart, 2009 ; National Collaborating Centre for Women's and Children 's Health, 2012; van Mello, 2012a; Rana et al., 2013) .
Women without evidence of an intrauterine pregnancy (IUP) or an EP after evaluation with TVS are said to have a pregnancy of unknown location (PUL) Barnhart et al., 2011) . Approximately 7-20% of women who initially have a PUL have a final diagnosis of EP (Barnhart, 2009; Kirk et al., 2009) . Managing a PUL is often difficult due to the possibility of serious medical and ethical consequences of a misdiagnosis; premature intervention may result in termination of a viable pregnancy, but an EP left untreated may rupture (Barnhart, 2012) .
Women for whom a diagnosis cannot be determined at presentation are typically reassessed after an interval of 48 h. The change in hCG values can then be compared with previously determined expected 2-day changes in hCG for IUP and spontaneous miscarriage (SM) (Kadar et al., 1981; Barnhart et al., 2004a,b; Seeber et al., 2006) . Values that do not rise or fall fast enough raise the suspicion of an EP. Others have used logistic regression modeling of the initial serum hCG level and the ratio of the first two hCG values (48 h apart) to predict outcome (Condous et al., 2004; Kirk et al., 2006; Condous et al., 2007a,b; van Mello 2012b) . This strategy has been validated in a population similar to that in which it was developed (Van Calster et al., 2013), but did not perform well in a US population (Barnhart et al., 2010) .
A potential reason why a model based on only two data points may not predict correctly is that the ratio of first two hCG values may be falsely reassuring or falsely 'abnormal'. Additional time and data may better reflect the viability and/or location of a gestation. It is common clinical practice for patients with a PUL to return 2-5 days after their second visit for another hCG value, although there is no defined standard of care regarding time and frequency of hCG values. The change in hCG values can then be compared again to the expected rise or fall after 4 or 7 days. A longer evaluation time can increase the chance of rupture of an EP and may also be burdensome to patients in terms of time, cost and other factors associated with multiple clinic visits. However, an increased number of visits where hCG values can be compared may increase the accuracy of diagnosis. Quantifying the increase in accuracy is the goal of this research.
This study aims to compare the accuracy of predicted outcomes at Days 2, 4 and 7 after initial presentation to determine whether EP predictions significantly improve over time. If predictions do improve, this would imply that asking women to return later, which increases the time interval after initial presentation, may give better outcome predictions. Alternatively, if predictions do not improve, then additional surveillance or delays in surgical or medical intervention for those suspected to be at risk of EP would have limited benefit. Our hypothesis was that the accuracy of diagnosis can be improved with follow-up beyond Day 2 (48 h).
Materials and Methods

Sample selection
Data for this study were from the prediction of ectopic pregnancy (PEP) study, for which patient information was collected between 2007 and 2009 from three sites: the University of Pennsylvania, the University of Miami and the University of Southern California. Patients in the database presented with pain and/or bleeding during the first trimester of pregnancy. If patients were clinically stable, they were followed using standard clinical guidelines assessing the change in hCG over time to that expected for a potentially viable or spontaneously resolving gestation (Seeber et al., 2006; Morse et al., 2012) .
Women were included in the study if they did not have signs of an intrauterine or extrauterine gestation on TVS at presentation, had at least two hCG values (at least 1 day apart) and where the pregnancy outcome was definitively known after follow-up. Patients were excluded if the pregnancy location and viability were diagnosed or if they had hCG levels .10 000 mIU/ml at presentation. Women were also excluded from analysis if the outcome was determined by hCG values that would not permit prediction of diagnosis at Days 2, 4 and/or 7. Each patient was diagnosed with an EP, IUP or SM (spontaneously resolved PUL or chorionic villi identified in uterine contents) using a definition as described in a consensus guideline (Barnhart et al., 2011) . Resolution of serum hCG was defined as at least two decreasing serum hCG measurements with the final level ,25 mIU/ml. Days to clinical diagnosis were calculated as the number of days from the date of initial presentation to the date of definitive diagnosis.
Model based classification
Our primary question of interest is whether prediction of EP improves, from that predicted using two hCG values 48 h apart (diagnosis on Day 2), on Day 4 (using three hCG values 48 h apart) or on Day 7 (using three hCG values: presentation, 2 days later and then 5 days later on Day 7 after initial presentation). First, the slopes of hCG values from presentation to Day 2 were determined to be rising or falling.
For the hCG values that were rising, the slopes were compared with the minimum expected slope for an IUP on Day 2. We used three different thresholds to define the minimum expected increase in hCG to define a potentially viable gestation: (i) A 66% rise in 2 days as recommended by Kadar in 1981 (Kadar et al., 1981 , (ii) a 53% increase as proposed by Barnhart in 2004 based on the 99th percentile for an intrauterine gestation (Barnhart et al. 2004b) and (iii) a 35% rise based on the 99.9th percentile for an intrauterine gestation (Seeber et al., 2006; Morse et al., 2012) . On Day 2 after presentation, a patient was classified as an IUP if the slope in hCG values from Day 0 to 2 was greater than the predefined threshold (i.e. 66% 2-day increase for an IUP).
For women who had hCG values that were falling, the slope of the hCG curve was compared with the 90th percentile maximum expected slope for an SM based on initial hCG value (Barnhart et al., 2004a) . First, we matched the woman's initial hCG value with the closest initial hCG reported in Barnhart et al. (2004a) to determine her maximum expected slope for an SM. If the slope of her hCG values fell by more than the reported 90th percentile slope from Days 0 to 2, her predicted outcome on Day 2 was an SM. Those who were not classified as an IUP or an SM on Day 2 were classified as an EP, meaning they were at risk for an EP.
To predict outcomes on Day 4, another 48 h after Day 2, a similar procedure was implemented to classify patients as IUP, EP or SM. To predict outcomes on Day 7, 5 days after Day 2, we first determined if the hCG values were rising or falling from Days 2 to 7. In cases when hCG values were rising, the 66% bound was extrapolated assuming a linear rise in log hCG values to define a 5-day lower bound as in Barnhart et al. (2004b) . A patient was reclassified as an IUP on Day 7 if the slope in hCG values from Days 2 to 7 was greater than the 5-day IUP bound. Those with falling hCG values were classified as an SM if the values fell faster than the expected 5-day maximum rise for an SM. Those not classified as an IUP or SM were classified as an EP. The procedure was then repeated using the 53 and 35% expected 2-day IUP rise bounds.
A secondary question of interest is whether predictions improve from Days 4 to 7, or by adding a fourth hCG measurement after a third hCG measurement on Day 4. Predictions for Day 7 were determined based on the expected 3-day rise for IUP, extrapolated from the 66, 53 and 35% 2-day bounds, and on the expected 3-day fall for SM.
Imputation of missing hCG values
As with many observational studies, patients often do not return on schedule to have their hCG values measured on Days 2, 4 and 7 after presentation, but had hCG measurements on nearby days. We considered 1-2 days from the desired day close enough to allow for estimation of the hCG values on the desired day using the following imputation scheme. We assumed a linear relationship between log-transformed hCG values and day (Barnhart et al., 2004b) . We also chose to interpolate a missing value from a later day over extrapolating the value from an earlier day whenever possible. Observed values were only used once for imputation and were not used again to impute the value of another day. When imputation using these guidelines was not possible, the value was considered missing. The imputed values were then used to determine patients' predicted outcomes as described above.
Some patients had missing values at Day 4 and/or Day 7 because a definitive diagnosis was determined prior to those dates. For these patients, we assume the latest prediction available would have carried over to subsequent days. For example, for a patient who has an EP prediction at Day 2, SM prediction at Day 4 and definitive diagnosis on Day 4, we would assume their Day 4 prediction would have carried over and assign a prediction of SM for Day 7. This assumption was conservative, as it only biased the estimated improvement toward the null hypothesis of no improvement.
Statistical analysis
Since our primary goal was to predict EP, we combined the IUP and SM predictions into one 'non-EP' group for the evaluation of improvement in EP prediction. For each IUP bound and pair of days (Days 0 -2, Days 2 -4, Days 2 -7 and Days 4 -7), we compared the predicted outcomes to the ultimate outcomes to determine sensitivity and specificity of the EP predictions. Improvement in prediction with additional days was quantified using the net reclassification improvement (NRI) (Pencina et al., 2008) , which quantifies changes in both sensitivity and specificity for paired data. Since the definition of improvement of prediction depends on the definitive diagnosis, the total NRI is the sum of two quantities: the component representing net improvement for those whose definitive diagnosis is EP, NRI E and the component representing net improvement for those whose definitive diagnosis is non-EP, NRI N . We calculate these statistics using each IUP bound and each pair of days and test the null hypothesis that the NRI or either of its components significantly differ from zero using a Wald test statistic. Two-sided P-values are reported for all statistical tests, with a value ≤0.05 being considered statistically significant.
Results
Sample characteristics
Out of 1701 women in the study database, 646 women met the inclusion criteria and had outcome predictions for at least 2 days to compose our final sample. A flow chart describing the inclusion and exclusion of patients is shown in Figure 1 . The chart also shows how many of the 646 women were used in each part of the analysis, including the number of those women whose outcome predictions were based on original observed hCG data, imputed hCG values or carried-over predictions. Demographic characteristics by ultimate outcomes of those included in the analysis are presented in Table I . The overall test characteristics for using hCG values to predict outcomes using each pair of days are presented in Table II . Of note, an increase in sensitivity for the diagnosis of EP was observed with the addition of a third hCG obtained on Day 4 or 7, when compared with prediction using only two values (on the day of presentation and Day 2). This increase was observed with all three IUP bounds. There also seems to be a slight increase in specificity of EP diagnosis with a third hCG measurement.
Assessment of imputation
To reduce the amount of missing data, and preserve statistical power, the hCG values for specific days of interest were imputed. Therefore, we attempted to assess the potential for bias that could be introduced by our imputation by comparing outcome predictions based on imputed values to outcome predictions made using only observed days of measurement. For example, if a patient had their Day 2 hCG value interpolated from their Day 3 hCG value, we calculated the slope from presentation to Day 3. Assuming the slope was negative and their initial hCG value was 250, we compared the observed slope to the 48% expected decline (Barnhart et al., 2004a) on Day 3 to determine an 'observed day' prediction. We then compared this to the 'imputed day' prediction. Since expected changes in hCG levels from presentation to Day 1 and from presentation to days after Day 7 are not reported in previous literature, we only compare imputations from Day 3 through Day 6.
Out of 173 predictions using Day 3 values to interpolate Day 2 values, only 1 was discordant: the 'imputed day' prediction was EP and 'observed day' prediction was SM. This was consistent across the three IUP bounds. The final outcome for this patient was SM. Out of 211 predictions imputed for Day 4 (from Days 3, 5 and 6), none were discordant. Out of 47 predictions imputed for Day 7 (from days 5 and 6), 1 was discordant: the 'imputed day' prediction was SM and 'observed day' prediction was EP across all three IUP bounds. The final outcome for this patient was SM.
Net reclassification improvement
There were 527 women who had predicted outcomes based on three hCG measurements at presentation, Days 2 and 4. Of these, 137 (26.0%) had a definitive EP diagnosis and 390 (74.0%) had a definitive diagnosis of IUP or SM. A total of 495 had predicted outcomes based on three hCG measurements at presentation, Days 2 and 7. Of these, 139 ultimately had EPs (28.1%). Predicted outcomes for 376 women were based on hCG measurements on Days 2, 4 and 7, and these included 130 EPs (34.6%). The estimated NRI and its components, variance estimates, tests of statistical significance and 95% confidence intervals are shown in Table III .
Focusing on the currently recommended minimum 2-day rise for an IUP bound of 53%, there was an improvement in predicted diagnoses when hCG values beyond Day 2 were considered. A net 9.3% of women had a correct change in prediction from that predicted on Day 2 when considering a third hCG value on Day 4. This result was statistically significant (P ¼ 0.015). Similarly, we found a significant net improvement in diagnoses from that predicted on Day 2 for 6.7% of women when a third hCG value was added on Day 7 (P ¼ 0.031). Similar results were obtained when using the 66 and 35% bounds, although the net improvement from Days 2 to 7 using the 66% bound did not achieve statistical significance. We also explored whether an additional hCG value on Day 7 in addition to Day 4 would have improved diagnoses even further. No matter what bound we used, we saw a positive net improvement, but the magnitude was small. None of these improvements achieved statistical significance. Therefore, adding a fourth hCG value may not give additional benefit to the accuracy of diagnoses.
Discussion
Evaluation of serial hCG measurements can be used to aid prediction of pregnancy location and viability in women with a PUL. However, the use of hCG values is not diagnostic (Barnhart, 2012; Morse et al., 2012) . Prediction of outcome based on the first two HCG values is commonly used, but is not always accurate (Barnhart et al., 2010; Van Calster et al., 2013) . A danger exists if the prediction based on the first two hCG values is inaccurate. Women with an EP can be missed, and women may be falsely informed that they have a non-viable gestation.
These data demonstrate that diagnoses that are predicted on only two hCG values can be inaccurate, and importantly, could have been corrected with a third hCG value in 7-13% of women. In other words, the diagnosis in at least 1 out of every 15 women with a PUL was corrected with the addition of a third serum hCG measurement (compared with that predicted based on the first two values) These significant improvements indicate that data beyond the first 48 h are necessary.
The improvement in prediction of ultimate outcome with additional information beyond the first two hCG values was only minimally sensitive to the rise in hCG used to define a potentially viable gestation. We found a similar improvement in predictions of outcome when using a 66, 53 or 35% expected 2-day rise to define a potentially viable intrauterine gestation. This indicates that the improvement in diagnosis for a woman with a PUL is a result of obtaining a third hCG value, not the specific threshold used to define viability.
The net improvements in diagnosis were similar whether the third hCG value was collected on Day 4 or 7 (when compared with predicted diagnosis on Day 2). This suggests that the net improvement is due to the ability to compare a third hCG value to the first two values rather than the extended time from presentation. The extra time between Days 4 and 7 did not dramatically affect the reclassification. However, because there was significant positive improvement in diagnosis with a third hCG obtained at Day 4 or 7, the choice of when to get the third hCG should be guided by clinical circumstances.
There was a small additional positive improvement in reclassification if a fourth hCG value was obtained on Day 7 (in addition to a value on Day 4), but the positive benefit was not statistically significant. This suggests that the greatest improvement in diagnosis was achieved after three hCG values. In general, the shape of the curve generated by serial hCG values is apparent with three values. The benefit of obtaining additional values depends on the specific clinical situation.
One drawback to obtaining additional hCG measurements is a possible increase in time to diagnosis, and more time for a possible rupture of an EP. No EP ruptures were observed in our sample, which is consistent with other literature that found ,1% of patients with PUL experienced a rupture during the course of determining diagnosis. Therefore, it appears that one can significantly improve diagnoses by waiting for a third hCG value without putting women in harm's way. However, this study was retrospective and the impact of a change in care should be evaluated with prospectively obtained data.
The study used the Net Reclassification Improvement statistic (Pencina et al., 2008) , which simultaneously takes into account a reclassification from an incorrect diagnosis to a correct diagnosis and reclassification of a correct diagnosis to a false diagnosis. This metric is maybe more intuitive for clinical purposes than sensitivity and specificity, as sensitivity and specificity evaluate the number of women identified with disease (or no disease) but not the false diagnosis of each. The area under the receiver operator curve (AUC) is a summary measure of sensitivity and specificity, but may not reflect clinically important changes in the individual misdiagnosis as it reflects a balance of sensitivity and specificity. Thus, the use of net reclassification may reflect an important clinical improvement when comparing different strategies that would not be appreciated using a metric such as AUC. , the net reclassification improvement in EP prediction among those with an ultimate EP diagnosis and NRI N , the net reclassification improvement in EP prediction among those with an ultimate IUP or SM diagnosis. IUP, intrauterine pregnancy; SM, spontaneous miscarriage. *P , 0.05, **P , 0.01, ***P , 0.001.
There are a few limitations of this study. First, some patients did not have hCG values measured on exactly Days 2, 4 and 7. We did have some missing values and had to make assumptions to impute data, but our sensitivity analysis and conservative methods indicate results would be similar had we had complete data. Even with our imputations, the number of women with data on each day was not identical. Thus, the improvement from Days 2 to 4 and the improvement from Days 4 to 7 cannot be added to equal the improvement from Days 2 to 7. Secondly, because of the retrospective, observational nature of the study, our predictions based only on hCG values may not match actual diagnoses made by clinicians at the time of evaluation. Other clinical factors besides hCG must be considered during the course of management of the PUL, which limits the generalizability of the study results to all patients with PUL. Thirdly, while our quantification of NRI treats both types of misclassification equally, the clinical consequences of misdiagnosis of an IUP are quite different from that of an SM. NRI can only accommodate binary outcomes rather than ternary outcomes. As prediction of EP was our primary objective, where applicable, IUP and SM predictions were grouped as non-EP. Finally, our data were collected from large academic centers and so the results may not be directly generalizable to other community settings. Despite these limitations, we feel that our study has some important clinical implications.
Prediction of diagnosis of a woman with a PUL based on only two hCG values can be problematic, resulting in misdiagnosis and potential interruption of a desired pregnancy. Diagnosis can be corrected in 7-13% of women when a third hCG value is obtained on Day 4 or 7 after initial presentation. Taking more time to assess the growth or resolution of a PUL will minimize premature intervention in viable gestations and reduce the risk of missing the diagnosis of an EP that may initially masquerade as a viable gestation or resolving PUL. However, serial hCG values are not diagnostic of the location or viability of a pregnancy. Other clinical factors, such as patient stability and results from other tests, such as a single serum progesterone measurement, can help to determine pregnancy viability (ver Haegen et al., 2012) and should be considered when determining a definitive diagnosis. In real-time clinical practice, the direction of serial hCG values determines the importance of misdiagnosis. In women with rising hCG values, the error of interest is a false-positive diagnosis of an EP (at the expense of an IUP). In this case a third hCG value on Day 4 may provide valuable information. In women with falling hCG values, the error of interest is the false-negative diagnosis of EP (perhaps resulting in rupture). In the case of women with minimal symptoms, a repeat hCG on Day 7 (or a week after presentation) may be safe and efficient.
